BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36517063)

  • 1. Is metabolic syndrome a modifiable risk factor for gout?
    Saudi Med J; 2022 Dec; 43(12):1402. PubMed ID: 36517063
    [No Abstract]   [Full Text] [Related]  

  • 2. Is metabolic syndrome a modifiable risk factor for gout?
    Neurosciences (Riyadh); 2023 Jul; 28(3):206. PubMed ID: 37482376
    [No Abstract]   [Full Text] [Related]  

  • 3. Is metabolic syndrome a modifiable risk factor for gout?
    Saudi Med J; 2023 May; 44(5):522. PubMed ID: 37182916
    [No Abstract]   [Full Text] [Related]  

  • 4. Is metabolic syndrome a modifiable risk factor for gout?
    Neurosciences (Riyadh); 2023 Jan; 28(1):72. PubMed ID: 36617451
    [No Abstract]   [Full Text] [Related]  

  • 5. Altered Risk of Incident Gout According to Changes in Metabolic Syndrome Status: A Nationwide, Population-Based Cohort Study of 1.29 Million Young Men.
    Eun Y; Han K; Lee SW; Kim K; Kang S; Lee S; Cha HS; Koh EM; Kim H; Lee J
    Arthritis Rheumatol; 2023 May; 75(5):806-815. PubMed ID: 36415898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and characteristics of metabolic syndrome in gout patients in a hospital setting in sub-Saharan Africa.
    Doualla-Bija M; Lobe Batchama Y; Moutchia-Suh J; Ama Moor VJ; Kamdem F; Lekpa FK; Luma Namme H
    Diabetes Metab Syndr; 2018 Nov; 12(6):1007-1011. PubMed ID: 29980454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome: prevalence and risk factors in Korean gout patients.
    Jung JH; Song GG; Ji JD; Lee YH; Kim JH; Seo YH; Choi SJ
    Korean J Intern Med; 2018 Jul; 33(4):815-822. PubMed ID: 27729624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of change in metabolic syndrome status with altered risk of incident gout: comment on the article by Eun et al.
    Wang G; Zhuo N; Tang M; Xue L; Liu Z
    Arthritis Rheumatol; 2023 Jun; 75(6):1080-1081. PubMed ID: 36575802
    [No Abstract]   [Full Text] [Related]  

  • 9. Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?
    Shah A; Keenan RT
    Curr Rheumatol Rep; 2010 Apr; 12(2):118-24. PubMed ID: 20425020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of the Incidence and Critical Risk Factors of Metabolic Syndrome in Patients With a Rheumatic Disease or Gout.
    Oh H; Park J; Yoon Y; Seo W
    Orthop Nurs; 2019; 38(3):201-208. PubMed ID: 31124872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease.
    Borghi C; Agabiti-Rosei E; Johnson RJ; Kielstein JT; Lurbe E; Mancia G; Redon J; Stack AG; Tsioufis KP
    Eur J Intern Med; 2020 Oct; 80():1-11. PubMed ID: 32739239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gout and Metabolic Syndrome: a Tangled Web.
    Thottam GE; Krasnokutsky S; Pillinger MH
    Curr Rheumatol Rep; 2017 Aug; 19(10):60. PubMed ID: 28844079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients With Early-Onset Gout and Development of Earlier Severe Joint Involvement and Metabolic Comorbid Conditions: Results From a Cross-Sectional Epidemiologic Survey.
    Pascart T; Norberciak L; Ea HK; Guggenbuhl P; Lioté F
    Arthritis Care Res (Hoboken); 2019 Jul; 71(7):986-992. PubMed ID: 30022604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Study of Metabolic Parameters in Patients with Gout: A Single Center Study from Nepal.
    Vaidya B; Baral R; Lama LD; Joshi R; Bhochhibhoya M; Nakarmi S
    Endocr Metab Immune Disord Drug Targets; 2021; 21(6):1090-1095. PubMed ID: 32819238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The epidemiology and genetic of gout].
    Bardin T; Richette P
    Presse Med; 2011 Sep; 40(9 Pt 1):830-5. PubMed ID: 21752574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidities in patients with crystal diseases and hyperuricemia.
    Sattui SE; Singh JA; Gaffo AL
    Rheum Dis Clin North Am; 2014 May; 40(2):251-78. PubMed ID: 24703346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on Importance of Diet in Gout.
    Beyl RN; Hughes L; Morgan S
    Am J Med; 2016 Nov; 129(11):1153-1158. PubMed ID: 27452679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between metabolic syndrome severity and the risk of mortality in gout patients: a population-based study.
    Schlesinger N; Elsaid MI; Rustgi VK
    Clin Exp Rheumatol; 2022 Mar; 40(3):631-633. PubMed ID: 35238754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperuricemia and gout: The impact of ultrasonography].
    García Puig J; de Miguel E
    Med Clin (Barc); 2016 Jan; 146(2):67-8. PubMed ID: 26183419
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased frequency of metabolic syndrome and its individual metabolic abnormalities in Japanese patients with primary gout.
    Inokuchi T; Tsutsumi Z; Takahashi S; Ka T; Moriwaki Y; Yamamoto T
    J Clin Rheumatol; 2010 Apr; 16(3):109-12. PubMed ID: 20375819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.